Cabozantinib in advanced renal cell carcinoma: a METEOR impact on clinical practice

Por Grassi, Paolo, Verzoni, Elena, Mennitto, Alessia, Procopio, Giuseppe
Publicado no Transl Androl Urol (2016)

Predicting Molecular Models: Where Are We Going?

Por Ratta, Raffaele, Verzoni, Elena, Grassi, Paolo, Niger, Monica, Procopio, Giuseppe
Publicado no EBioMedicine (2015)

Response to Targeted Therapy in Urachal Adenocarcinoma

Por Testa, Isabella, Verzoni, Elena, Grassi, Paolo, Colecchia, Maurizio, Panzone, Filomena, Procopio, Giuseppe
Publicado no Rare Tumors (2014)

Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience

Por Mennitto, Alessia, Grassi, Paolo, Ratta, Raffaele, Verzoni, Elena, Prisciandaro, Michele, Procopio, Giuseppe
Publicado no Ther Adv Urol (2016)

Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib

Por Grassi, Paolo, Verzoni, Elena, Porcu, Luca, Iacovelli, Roberto, de Braud, Filippo, Procopio, Giuseppe
Publicado no Ther Adv Urol (2015)

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy

Por Grassi, Paolo, Verzoni, Elena, Ratta, Raffaele, Mennitto, Alessia, de Braud, Filippo, Procopio, Giuseppe
Publicado no Drug Des Devel Ther (2016)

Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors

Por Verzoni, Elena, Grassi, Paolo, Ratta, Raffaele, Niger, Monica, De Braud, Filippo, Valdagni, Riccardo, Procopio, Giuseppe
Publicado no Ther Adv Med Oncol (2016)

Targeted treatments in advanced renal cell carcinoma: focus on axitinib

Por Verzoni, Elena, Grassi, Paolo, Testa, Isabella, Iacovelli, Roberto, Biondani, Pamela, Garanzini, Enrico, De Braud, Filippo, Procopio, Giuseppe
Publicado em 2014

Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma

Por Zanardi, Elisa, Verzoni, Elena, Grassi, Paolo, Necchi, Andrea, Giannatempo, Patrizia, Raggi, Daniele, De Braud, Filippo, Procopio, Giuseppe
Publicado no Ther Adv Urol (2015)

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential

Por Pusceddu, Sara, Verzoni, Elena, Prinzi, Natialie, Mennitto, Alessia, Femia, Daniela, Grassi, Paolo, Concas, Laura, Vernieri, Claudio, Lo Russo, Giuseppe, Procopio, Giuseppe
Publicado no Ther Adv Med Oncol (2017)

Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis

Por Grassi, Paolo, Doucet, Ludovic, Giglione, Palma, Grünwald, Viktor, Melichar, Bohuslav, Galli, Luca, De Giorgi, Ugo, Sabbatini, Roberto, Ortega, Cinzia, Santoni, Matteo, Bamias, Aristotelis, Verzoni, Elena, Derosa, Lisa, Studentova, Hana, Pacifici, Monica, Coppa, Jorgelina, Mazzaferro, Vincenzo, de Braud, Filippo, Porta, Camillo, Escudier, Bernard, Procopio, Giuseppe
Publicado no PLoS One (2016)

Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study

Por Verzoni, Elena, Giorgi, Ugo De, Derosa, Lisa, Caffo, Orazio, Boccardo, Francesco, Facchini, Gaetano, Porcu, Luca, Vincenzo, Fabio De, Zaniboni, Alberto, Chiuri, Vincenzo Emanuele, Fratino, Lucia, Santini, Daniele, Adamo, Vincenzo, Vivo, Rocco De, Dinota, Angelo, Messina, Caterina, Ricotta, Riccardo, Caserta, Claudia, Scavelli, Claudio, Susi, Marina, Tartarone, Alfredo, Surace, Giuseppe, Mosca, Alessandra, Bruno, Michele, Barni, Sandro, Grassi, Paolo, Procopio, Giuseppe
Publicado no Oncotarget (2016)